Agents for ameliorating low vasopressin level
US7655227B1 · kind B1 · utility
0Cited by
9References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 3, 2000 |
| Grant date | Feb 2, 2010 |
| Priority date | — |
| Expiry date | Jul 3, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K16/26
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides an agent for ameliorating low vasopressin level, which comprises, as an active ingredient, a substance capable of inhibiting the binding between parathyroid hormone-related peptide (PTHrP) and a receptor thereof; and an agent for ameliorating a symptom caused by a decrease in vasopressin level, which comprises, as an active ingredient, a substance capable of inhibiting the binding between parathyroid hormone-related peptide (PTHrP) and a receptor thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.